Sunday, October 4, 2020

USFDA cites CGMP violations at Panacea Biotec#39;s Baddi plant in warning letter

USFDA cites CGMP violations at Panacea Biotec#39;s Baddi plant in warning letter In a letter to Panacea Biotec Managing Director Rajesh Jain, the USFDA said its inspectors, from February 10-20, 2020, found significant deviations from standard manufacturing practices at company#39;#39;s Baddi plant.

from Moneycontrol Business News https://ift.tt/33vFak2
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Global Market Today: Asian markets temper Iran deal optimism, BOJ decision in view

Asian stocks saw a modest rise, following a rally on news of a peace deal between Iran and the U.S. Investors are now focused on central ban...